Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I wish there was a date on that article. Great article by the way..
Aside from speculation, we have nothing concrete to go on to that effect...
Articles like this only fuel the hype, imo. The main driver here imo should be the fact that this company has a drug that would make Chemotherapy obsolete. There are plenty of reasons why the world needs this, not the least of which is the fact that this new virus attacks people's immune system, and Chemotherapy severely impares the immune system. Mipsagargin would undoubtedly save a lot of lives.
The 785 Arbor Rd. address is a house in a neighborhood, could that be correct?
Mipsagargin needs to be brought to the attention of president Trump.
Especially now when we have an out of control virus that attacks the immune system..
Mipsagargin could do away with the need for immune system destroying Chemotherapy and save a lot of lives.
Why it's not $1 -manipulation both in markets and public opinion..
This is what's been done to silver.. Smart money is figuring this out though...
Why this isn't already at $1 ? My guess is manipulation -both in the markets and in public opinion.
Just look at silver -grossly undervalued...
Correct. That and the potential answer to cancer -Mipsagargin- This drug could make Chemotherapy obsolete...
it seems that Inspyr was concerned about the possibility of a hostile takeover and wanted to protect themselves and their intellectual property..?
What is like to know - is a little more about Conor Flannery...
Is he still the principal shareholder?
***And***
Does Mr. Flannery have Inspyr's best interests at heart..?
Inspyr is probably fighting some pretty strong headwinds from big pharma and money behind Chemotherapy...
And similarly when it goes up, the same standard methodologies are applied ad nauseum to push the price back down. Smells like desperation to grab as many shares as they can at cheaper prices. You don't see that?
That was a little rude and un-called for.
Dude, Mipsagargin is a cancer killing drug that could make chemotherapy obsolete. What more do you need?
Everyone knows chemotherapy is evil. But that's the 'cure' everyone turns to despite. The side effects of chemo are 100% God-awful. Mipsagargin could change all that.
Phase 3 trials for Mipsagargin - how will we know when they begin?
I see phase 2 trials were in 2015?
How will we know when Inspyr begins the phase 3 trials for Mipsagargin??
This tweet by the National Cancer Institute is very interesting... Yeah Chemo weakens the immune system.
Mipsagargin would seem to be a wonderful alternative to Chemotherapy, w/o the horrible side effects.
It seems a drug like Mipsagargin is highly needed in this day and age... Nice!
Yes this is very interesting indeed. Hmmm...
Thanks for posting.
The screenshot with the info of Conor Flannery's stock position - which form was that on?
Fwiw, Inspyr created a Facebook page January 9, 2020. The most recent posts on the page are from late February...
Good post... Something is afoot...
They were beset by a lack of funding in 2018. Read their 10-k annual report for 2018, it explains it all. I read it today. It might seem kind of boring, but I found it rather interesting...
Plus a press release to help it along would be nice....
I thought they had to state that in either the annual or quarterly Sec filings?
Old article, I don't see the relevance to today...?
As calculated in accordance with Rule 13d-3 of the Securities Exchange
Act of 1934, as amended, (i) Sabby Healthcare Master Fund,
Ltd. and Sabby Volatility Master Fund, Ltd. beneficially own 1,137,260
and 1,137,260 shares of the Issuer's common stock (common shares),
respectively, representing approximately 9.99% and 9.99% of the Common
Stock, respectively, and (ii) Sabby Management, LLC and Hal Mintz each
beneficially own 1,137,260 shares of the common shares,
representing approximately 9.99% of the common shares. Sabby Management,
LLC and Hal Mintz do not directly own any common shares, but
each indirectly owns 1,137,260 common shares. Sabby Management,
LLC, a Delaware limited liability company, indirectly owns
1,137,260 common shares because it serves as the investment manager of
Sabby Healthcare Master Fund, Ltd. and Sabby Volatility Warrant Master
Fund, Ltd., Cayman Islands companies. Mr. Mintz indirectly owns
1,137,260 common shares in his capacity as manager of Sabby Management,
LLC.
I took this to mean 1,137,260 shares are to be controlled by the mentioned entities.. Am I reading it wrong?
I'll do that, thanks...
I'm not sure that is good news for us. Gate foundation is into vaccines. Bill Gates wants to vaccinate everyone and everything. Inspyr is into therapeutics treatments for diseases. I don't think Gates could give 2 shits about that...
I've been doing some researching of Sabby management's position here.
According to Sec filings SC 13G/A on
11-26-18, Sabby acquired 4,681,207 shares of Inspyr..
Another filing on 1-21-20 stated Sabby owned 1,137,260 shares...
Does anyone know what happened there? Did Sabby acquire 1,137,260 additional shares on top of the 4,681,207, or did Sabby sell a bunch of shares and now only owns 1,137,260....??? Any insight would be helpful. Thanks..
Please post a link for us..
2020-04-08
Application status is Active
2020-07-28
Anticipated expiration
2020-04-08
Application status is Active
2020-07-28
Anticipated expiration
This one is still active, but is set to expire on July 28, 2020
https://patents.google.com/patent/US20120309692/de
Look at the first link :
2020-04-08
Application status is Abandoned
Yes, I looked at their website...
I haven't read anything about NSPX creation of angiotensin.. please post where you saw this... The substances NSPX created are a2a/a2b dual antagonist...
You're needlessly adding to the hype.
Neither of the 2 articles you posted mentioned anything having to do with NSPX.
If you snooze and wait for news, you're gonna lose bro...
Is Inspyr still mergered with Lewis and Clark ? Anyone know...?
Form 10-k should be coming out soon it looks like. Last one was filed 4-26-2019...